liraglutide
UkraineDrugs containing this active substance
-
The drug is used to treat inadequately controlled type 2 diabetes mellitus in adults, adolescents, and children aged 10 years and older. It is used both as monotherapy and in combination with other diabetes treatments.
Form: solution for injection
Active substance Dosage liraglutide 6 mg/ml ATC: A10BJ02
Manufacturer: Ambiopharm, Inc (stability control) / Profarma UAB (batch control)
-
The drug is used for weight reduction as an adjunct to a reduced-calorie diet and increased physical activity. It is prescribed for adults with obesity (BMI ≥ 30 kg/m²) or overweight (BMI from 27 to 30 kg/m²) with comorbidities such as prediabetes, type 2 diabetes, hypertension, dyslipidemia, or sleep apnea. The drug may also be used for weight management in children aged 12 years and older.
Form: solution for injection
Active substance Dosage liraglutide 6 mg/ml ATC: A10BJ02
-
The drug is used to treat inadequately controlled type 2 diabetes mellitus in adults, adolescents, and children aged 10 years and older. It can be used as monotherapy (if metformin is not suitable) or in combination with other diabetes treatments.
Form: solution for injection
Active substance Dosage liraglutide 6 mg/ml ATC: A10BJ02
-
The drug is used to improve blood sugar control in adults with type 2 diabetes as an adjunct to diet, physical exercise, and other medications.
Form: solution for injection
Active substance Dosage insulin degludec 100 IU/ml liraglutide 3.6 mg/ml ATC: A10AE56